75057-11-3

Upstream product

• 64-19-7 acetic acid 
• 100835-66-3 2,2-bis-(p-methylthiophenyl)ethyl tosylate 
• 93017-98-2 2-Brom-1,1-bis-(4-methylmercapto-phenyl)-ethan 
• 19679-38-0 1,1,1-trichloro-2,2-bis-(4-methylsulfanyl-phenyl)-ethane 
• 75057-07-7 2,2-bis-(p-methylthiophenyl)-1-nitroethylene 
• 58477-22-8 4-methylthiobenzyltriphenylphosphonium chloride 
• 118578-86-2 diethyl 4-(methylmercapto)benzyl phosphonate 
• 3446-89-7 4-(Methylthio)benzaldehyde 
• 1078-28-0 6-methoxyquinaldine 
• 100-68-5 methyl-phenyl-thioether 
• 621-62-5 chloroacetaldehyde diethyl acetal 
• 75057-01-1 2,2-bis-(p-methylthiophenyl)ethylene 

Downstream Products

• 61812-41-7 1,2-bis(4-(methylthio)phenyl)ethane 

Relevant academic research and scientific papers

pH fluorescent compound with AIE characteristics, preparation and application of compound

The invention relates to a fluorescent probe compound (I) with AIE characteristics, a preparation method and an application of the compound. The detection principle of the fluorescence probe with AIEcharacteristics is that the compound (I) hardly emits li

Importance of direct metal-π coupling in electronic transport through conjugated single-molecule junctions

We study the effects of molecular structure on the electronic transport and mechanical stability of single-molecule junctions formed with Au point contacts. Two types of linear conjugated molecular wires are compared: those functionalized with methylsulfi

BISARYLCYCLOBUTENE DERIVATES AS CYCLOOXYGENASE INHIBITORS

The invention encompasses the novel compound of formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of formula (I).

Bisaryl cyclobutenes derivatives as cyclooxygenase inhibitors

The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. STR1 The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising

Substituent Effect Studies of Aryl-Assisted Solvolyses. I. The Acetolysis of 2,2-Bis(substituted phenyl)ethyl p-Toluenesulfonates

The substituent effect on the acetolysis of 2,2-bis(substituted phenyl)ethyl p-toluenesulfonates at 90.10 deg C can be described accurately in terms of the Yukawa-Tsuno (LArSR) relationship, giving a ρ value of -4.44 and an r value of 0.53. The substituent effect correlation of this system carrying two aryls is quite comparable to that of the 2-methyl-2-phenylpropyl system carrying a single aryl group, suggesting the close similarity in the structure of the transition states between the systems. The results can be reasonably accounted for on the basis of the accepted mechanism of this reaction, involving a rate-determining aryl-assisted transition state where only one aryl group of the two β-aryl groups participates.

Reduction of 2,2-Diaryl-1-nitroethylenes : New Synthesis of 2,2-Diarylacetaldehydes and 1,1,4,4-Tetraarylbuta-1,3-dienes

2,2-Diarylacetaldehydes (VII) have been obtained by selective and controlled reduction of 2,2-diaryl-1-nitroethylenes (IV) in acid medium, and also by acid hydrolysis of 2,2-diarylvinyl-N-acetamides (VI).Nitroalkenes (IV) have been prepared by the reaction of 2,2-diarylethylenes (I) with nitrous acid whereas N-acetamide derivatives (VI) have been obtained by reductive acetylation of the nitro compounds (IV).A number of 1,1,4,4-tetraarylbuta-1,3-dienes (XI) have been obtained by the condensation of 2,2-diarylacetaldehydes (VII) with appropriate 2,2-diarylethylenes (I).Structures of the products have been assigned on the basis of analytical data and chemical and spectral evidences.